Cancer Control Practices and Their Effect on the Cancer Burden
View the objectives of this area of research.
2008
Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, Ditommaso D, Karnaofski K, Gulati R, Penson DF, Feuer EJ. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control Mar 2008;19(2):175-81.
2007
Mariotto AB, Etzioni R, Krapcho M, Feuer EJ.
Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.
Cancer
1 May 2007;109(9):1877-86.
2006
Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
J Natl Cancer Inst Monogr
2006;(36):7-15.
Yu B.
Estimation of shared Gamma frailty models by a modified EM algorithm.
Computational Statistics and Data Analysis
30 Jan 2006;50:436-74.
2005
Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ.
Modeling the dissemination of mammography in the United States.
Cancer Causes Control
Aug 2005;16(6):701-12.
Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC.
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
Cancer
1 Nov 2005;104(9):1840-8.
2004
Feuer EJ, Boer R, Holford TR.
Developing and comparing population models for the early detection of cancer.
Statistical Methods in Medical Research
2004;13:419-420.
Feuer EJ, Etzioni R, Cronin KA, Mariotto A.
The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing.
Stat Methods Med Res
Dec 2004;13(6):421-42.
Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.
Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Med Care
Mar 2004;42(3):239-50.
Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
J Gen Intern Med
Feb 2004;19(2):146-55.
Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ.
An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States.
Am J Epidemiol
1 Dec 2004;160(11):1059-69.
2003
Shavers VL, Harlan LC, Winn D, Davis WW.
Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands.
Cancer Metastasis Rev
Mar 2003;22(1):25-38.
Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W.
Comparison of stomach cancer incidence and survival in four continents.
Eur J Cancer
Jul 2003;39(11):1603-9.
2002
Etzioni R, Berry KM, Legler JM, Shaw P.
Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
Urology
Feb 2002;59(2):251-5.
Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ.
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
J Natl Cancer Inst
3 Jul 2002;94(13):981-90.
Feuer EJ, Mariotto A, Merrill R.
Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.
Cancer
15 Aug 2002;95(4):870-80.
Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J.
Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
J Natl Cancer Inst
6 Nov 2002;94(21):1626-34.
2001
Cronin KA, Krebs-Smith SM, Feuer EJ, Troiano RP, Ballard-Barbash R.
Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States).
Cancer Causes Control
May 2001;12(4):305-16.
Knopf KB, Warren JL, Feuer EJ, Brown ML.
Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries.
Gastrointest Endosc
Nov 2001;54(5):563-71.
Potosky AL, Feuer EJ, Levin DL.
Impact of screening on incidence and mortality of prostate cancer in the United States.
Epidemiol Rev
2001;23(1):181-6.
2000
Legler JM, Gloeckler Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS.
RESPONSE: re: brain and other central nervous system cancers: recent trends in incidence and mortality.
J Natl Cancer Inst
5 Jan 2000;92(1):77A-8.
1999
Breen N, Wesley MN, Merrill RM, Johnson K.
The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study.
Ethn Dis
1999;9(1):111-25.
Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF.
Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.
J Natl Cancer Inst
16 Jun 1999;91(12):1033-9.
Feuer EJ, Merrill RM, Hankey BF.
Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
J Natl Cancer Inst
16 Jun 1999;91(12):1025-32.
Feuer EJ, Sheinfeld J, Bosl GJ.
Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer.
J Natl Cancer Inst
19 May 1999;91(10):816-8.
Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS.
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
J Natl Cancer Inst
16 Jun 1999;91(12):1017-24.
Legler JM, Gloeckler Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS.
RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality.
J Natl Cancer Inst
1 Dec 1999;91(23):2050A-22051.
Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS.
Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.
J Natl Cancer Inst
18 Aug 1999;91(16):1382-90.
Merrill RM, Feuer EJ, Warren JL, Schussler N, Stephenson RA.
Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.
Am J Epidemiol
15 Oct 1999;150(8):848-60.
1998
Etzioni R, Cha R, Feuer EJ, Davidov O.
Asymptomatic incidence and duration of prostate cancer.
Am J Epidemiol
15 Oct 1998;148(8):775-85.
Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS.
The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.
Cancer Causes Control
Oct 1998;9(5):519-27.
1997
Merrill RM, Brawley OW.
Prostate cancer incidence and mortality rates among white and black men.
Epidemiology
Mar 1997;8(2):126-31.
1996
Bunin GR, Feuer EJ, Witman PA, Meadows AT.
Increasing incidence of childhood cancer: report of 20 years experience from the greater Delaware Valley Pediatric Tumor Registry.
Paediatr Perinat Epidemiol
Jul 1996;10(3):319-38.
Merrill RM.
Changes in the use of radical prostatectomy for treating prostate cancer in the USA.
Lancet
5 Oct 1996;348(9032):963-4.
Merrill RM.
Stat Bite: Trends in prostate cancer incidence.
J Natl Cancer Inst
22 Nov 1996;88(22):1617.
Merrill RM.
Trends in prostate cancer incidence and surgery (Stat Bite).
J Natl Cancer Inst
Apr 1996;88:403.
Merrill RM, Potosky AL, Feuer EJ.
Changing trends in U.S. prostate cancer incidence rates.
J Natl Cancer Inst
20 Nov 1996;88(22):1683-5.
1995
Feuer EJ.
Incidence of testicular cancer in U.S. men (Stat bite).
J Natl Cancer Inst
1995;87(6):405.
Wun LM, Feuer EJ, Miller BA.
Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States?
Cancer Causes Control
Mar 1995;6(2):135-44.
1994
Feuer EJ, Frey CM, Brawley OW, Nayfield SG, Cunningham JB, Geller NL, Bosl GJ, Kramer BS.
After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
J Clin Oncol
Feb 1994;12(2):368-77.
Miller BA, Feuer EJ, Hankey BF.
The significance of the rising incidence of breast cancer in the United States.
Important Adv Oncol
1994193-207.
1993
Miller BA, Feuer EJ, Hankey BF.
Recent incidence trends for breast cancer in women and the relevance of early detection: an update.
CA Cancer J Clin
1993;43(1):27-41.
1992
Coleman EA, Kessler LG, Wun LM, Feuer EJ.
Trends in the surgical treatment of ductal carcinoma in situ of the breast.
Am J Surg
Jul 1992;164(1):74-6.
Feuer EJ, Wun LM.
How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach.
Am J Epidemiol
15 Dec 1992;136(12):1423-36.
Miller BA, Feuer EJ, Hankey BF.
Breast cancer.
N Engl J Med
10 Dec 1992;327(24):1756-7.
1991
Feuer EJ, Miller BA.
Stat Bite: Breast and Lung/Bronchus Cancers in U.S. Women by Geographic Area.
J Natl Cancer Inst
1991;83(20):1437.
Frey CM, Hartman AM.
Stat Bite: U.S. Trends in Melanoma Incidence and Mortality.
J Natl Cancer Inst
1991;83(23):1705.
Kessler LG, Feuer EJ, Brown ML.
Projections of the breast cancer burden to U.S. women: 1990-2000.
Prev Med
Jan 1991;20(1):170-82.
Miller BA, Feuer EJ, Hankey BF.
The increasing incidence of breast cancer since 1982: relevance of early detection.
Cancer Causes Control
Mar 1991;2(2):67-74.
Miller BA, Feuer EJ, Hankey BF.
Trends in invasive breast cancer incidence among American women (Stat Bite).
J Natl Cancer Inst
1991;83:678.
1990
Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW.
Rise in prostatic cancer incidence associated with increased use of transurethral resection.
J Natl Cancer Inst
17 Oct 1990;82(20):1624-8.
1989
Department of Health and Human Services.
Comments of the Department of Health and Human Services on the General Accounting Office`s Draft Report on Breast Cancer: Patients have yet to realize the benefits of adjuvant chemotherapy.
In:
Breast Cancer Patients` Survival.
Washington D.C.:
U.S. General Accounting Office;
Feb 1989.
p. 34-51.
1988
Brown CC, Kessler LG.
Projections of lung cancer mortality in the United States: 1985-2025.
J Natl Cancer Inst
2 Mar 1988;80(1):43-51.
1986
Levin DL, Gail MH, Kessler LG, Eddy DM.
A model for projecting cancer incidence and mortality in the presence of prevention screening, and treatment programs.
Cancer control objectives for the nation: 1985-2000. NCI Monographs Number 2.
1986.
NIH Pub. No.86-2880.
|